SUBSCRIBERS

Teva said to be close to buying generic drug unit of Allergan

Add BT as a preferred source

Published Sun, Jul 26, 2015 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Petah Tikva, Israel

TEVA Pharmaceuticals is in advanced talks to buy the generic drug division of Allergan for about US$45 billion, a person briefed on the matter said on Saturday.

A deal could be announced as soon as Monday, this person said, though talks are ongoing and may still fall apart. Should an agreement be reached, it would be the latest huge deal in a wave of mergers within the healthcare space, a spree that has ranged from drugmakers to insurance providers.

Share with us your feedback on BT's products and services

Feedback

TRENDING NOW

Property-based taxes may have limited room to run – and pushing them further risks hitting the wrong people, observers say.

In taxing wealth, how far can Singapore push property owners?

Chinese Foreign Minister Wang Yi stopped short of explicitly naming the US or Israel as aggressors, a telling omission from a country that otherwise speaks with little diplomatic timidity.

Beijing’s calculated silence on the Iran war

The iconic rainbow blocks of Rochor Centre were demolished in 2018 to 2019 to make way for the North-South Corridor.

20 photos that show how dramatically Singapore has changed in two decades

Andrew Lee, chairman of OCBC (right), and group chief executive Tan Teck Long speaking at Thursday's (Apr 16) AGM.

Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News